BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,409,040 | -19.9% | 199,017 | -20.4% | 0.00% | -20.0% |
| Q2 2023 | $1,759,169 | -11.9% | 249,882 | +4.3% | 0.01% | -16.7% |
| Q1 2023 | $1,997,263 | -6.8% | 239,480 | +28.3% | 0.01% | -14.3% |
| Q4 2022 | $2,141,996 | -10.0% | 186,585 | -1.2% | 0.01% | -12.5% |
| Q3 2022 | $2,380,000 | +14.8% | 188,902 | -3.6% | 0.01% | +60.0% |
| Q2 2022 | $2,073,000 | -46.4% | 195,900 | -17.6% | 0.01% | -37.5% |
| Q1 2022 | $3,867,000 | +7.5% | 237,800 | -8.4% | 0.01% | +14.3% |
| Q4 2021 | $3,597,000 | -3.6% | 259,700 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $3,732,000 | -9.1% | 259,700 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $4,106,000 | +50.1% | 259,700 | -3.4% | 0.01% | +33.3% |
| Q1 2021 | $2,735,000 | +25.7% | 268,900 | -7.9% | 0.01% | +20.0% |
| Q4 2020 | $2,175,000 | +85.7% | 292,000 | -14.3% | 0.01% | +66.7% |
| Q3 2020 | $1,171,000 | +6.5% | 340,900 | +47.7% | 0.00% | 0.0% |
| Q2 2020 | $1,100,000 | +140.7% | 230,800 | +1.0% | 0.00% | +50.0% |
| Q1 2020 | $457,000 | -19.8% | 228,600 | +38.5% | 0.00% | +100.0% |
| Q4 2019 | $570,000 | +20.5% | 165,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $473,000 | -18.2% | 165,100 | +8.2% | 0.00% | -50.0% |
| Q2 2019 | $578,000 | -52.4% | 152,600 | +2.3% | 0.00% | -33.3% |
| Q1 2019 | $1,214,000 | +33.7% | 149,200 | +32.6% | 0.00% | 0.0% |
| Q4 2018 | $908,000 | +18.7% | 112,500 | +12.2% | 0.00% | +50.0% |
| Q3 2018 | $765,000 | +33.0% | 100,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $575,000 | +115.4% | 100,300 | +79.1% | 0.00% | +100.0% |
| Q1 2018 | $267,000 | -2.9% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $275,000 | -6.1% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $293,000 | -5.8% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $311,000 | – | 56,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |